Biosynthesis of galactofuranose in kinetoplastids: Novel therapeutic targets for treating leishmaniasis and chagas' disease

Enzyme Research

Volumn 2011, Issue 1, 2011, Pages

  Oppenheimer, Michelle ^a   Valenciano, Ana L ^a,b   Sobrado, Pablo ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^b INSTITUTO TECNOLÓGICO DE COSTA RICA   (Costa Rica)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOFURANOSE; BETA GALACTOPYRANOSE; CARBOHYDRATE DERIVATIVE; CELL SURFACE PROTEIN; GLYCAN; GLYCOINOSITOLPHOSPHOLIPID; LIPOPHOSPHOGLYCAN; MUTASE; PHOSPHOLIPID DERIVATIVE; TRANSFERASE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GALACTOFURANOSYL TRANSFERASE; URIDINE DIPHOSPHATE GALACTOPYRANOSE MUTASE; URIDINE DIPHOSPHATE GLUCOSE 4 EPIMERASE;

CARBOHYDRATE ANALYSIS; CARBOHYDRATE SYNTHESIS; CELL ADHESION; CHAGAS DISEASE; DRUG TARGETING; ENZYME SYNTHESIS; HOST PARASITE INTERACTION; HUMAN; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIASIS; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARASITE VIRULENCE; PRIORITY JOURNAL; REVIEW; TRYPANOSOMA CRUZI;

KINETOPLASTIDA; MAMMALIA; PROTOZOA; TRYPANOSOMA CRUZI;

EID: 84858653974     PISSN: 20900406     EISSN: 20900414     Source Type: Journal    
DOI: 10.4061/2011/415976     Document Type: Review

References (109)

1. Crick D. C., Mahapatra S., Brennan P. J., Biosynthesis of the arabinogalactan-peptidoglycan complex of Mycobacterium tuberculosis. Glycobiology 2001 11 9 2-s2.0-0034770036
2. Stevenson G., Neal B., Liu D., Hobbs M., Packer N. H., Batley M., Redmond J. W., Lindquist L., Reeves P., Structure of the O antigen of Escherichia coli K-12 and the sequence of its rfb gene cluster. Journal of Bacteriology 1994 176 13 4144 4156 2-s2.0-0028355860 (Pubitemid 24191300)
3. Berst M., Hellerqvist C. G., Lindberg B., Lüderitz O., Svensson S., Westphal O., Structural investigations on T1 lipopolysaccharides. European Journal of Biochemistry 1969 11 2 353 359 2-s2.0-0014635336
4. Whitfield C., Richards J. C., Perry M. B., Clarke B. R., MacLean L. L., Expression of two structurally distinct D-galactan O antigens in the lipopolysaccharide of Klebsiella pneumoniae serotype O1. Journal of Bacteriology 1991 173 4 1420 1431 2-s2.0-0025975456
5. Weston A., Stern R. J., Lee R. E., Nassau P. M., Monsey D., Martin S. L., Scherman M. S., Besra G. S., Duncan K., McNeil M. R., Biosynthetic origin of mycobacterial cell wall galactofuranosyl residues. Tubercle and Lung Disease 1997 78 2 123 131 2-s2.0-0031417910 10.1016/S0962-8479(98)80005-1 (Pubitemid 28080550)
6. Bakker H., Kleczka B., Gerardy-Schahn R., Routier F. H., Identification and partial characterization of two eukaryotic UDP-galactopyranose mutases. Biological Chemistry 2005 386 7 657 661 2-s2.0-26844534219 10.1515/BC.2005.076 (Pubitemid 41460263)
7. Beverley S. M., Owens K. L., Showalter M., Griffith C. L., Doering T. L., Jones V. C., McNeil M. R., Eukaryotic UDP-galactopyranose mutase (GLF Gene) in microbial and metazoal pathogens. Eukaryotic Cell 2005 4 6 1147 1154 2-s2.0-20444477920 10.1128/EC.4.6.1147-1154.2005 (Pubitemid 40817473)
8. Nassau P. M., Martin S. L., Brown R. E., Weston A., Monsey D., Mcneil M. R., Duncan K., Galactofuranose biosynthesis in Escherichia coli K-12: identification and cloning of UDP-galactopyranose mutase. Journal of Bacteriology 1996 178 4 1047 1052 2-s2.0-0030029877 (Pubitemid 26048020)
9. Köplin R., Brisson J. R., Whitfield C., UDP-galactofuranose precursor required for formation of the lipopolysaccharide o antigen of Klebsiella pneumoniae serotype O1 is synthesized by the product of the rfbD(KPO1) gene. The Journal of Biological Chemistry 1997 272 7 4121 4128 2-s2.0-0031054244 10.1074/jbc.272.7.4121 (Pubitemid 27078477)
10. Sarvas M., Nikaido H., Biosynthesis of T1 antigen in Salmonella: origin of D-galactofuranose and D-ribofuranose residues. Journal of Bacteriology 1971 105 3 1063 1072 2-s2.0-0015027299
11. Richards M. R., Lowary T. L., Chemistry and biology of galactofuranose-containing polysaccharides. ChemBioChem 2009 10 12 1920 1938 2-s2.0-70349554368 10.1002/cbic.200900208
12. Kremer L., Dover L. G., Morehouse C., Hitchin P., Everett M., Morris H. R., Dell A., Brennan P. J., McNeil M. R., Flaherty C., Duncan K., Besra G. S., Galactan biosynthesis in Mycobacterium tuberculosis: identification of a bifunctional UDP-galactofuranosyltransferase. The Journal of Biological Chemistry 2001 276 28 26430 26440 2-s2.0-0035854786 10.1074/jbc.M102022200 (Pubitemid 37412862)
13. Pan F., Jackson M., Ma Y., McNeil M., Cell wall core galactofuran synthesis is essential for growth of mycobacteria. Journal of Bacteriology 2001 183 13 3991 3998 2-s2.0-0034971311 10.1128/JB.183.13.3991-3998.2001 (Pubitemid 32565479)
14. Dykhuizen E. C., May J. F., Tongpenyai A., Kiessling L. L., Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth. Journal of the American Chemical Society 2008 130 21 6706 6707 2-s2.0-44349186719 10.1021/ja8018687 (Pubitemid 351748397)
15. Dykhuizen E. C., Kiessling L. L., Potent ligands for prokaryotic UDP-galactopyranose mutase that exploit an enzyme subsite. Organic Letters 2009 11 1 193 196 2-s2.0-59649097634 10.1021/ol802094p
16. Scherman M. S., Winans K. A., Stern R. J., Jones V., Bertozzi C. R., McNeil M. R., Drug targeting Mycobacterium tuberculosis cell wall synthesis: development of a microtiter plate-based screen for UDP-galactopyranose mutase and identification of an inhibitor from a uridine-based library. Antimicrobial Agents and Chemotherapy 2003 47 1 378 382 2-s2.0-0037226407 10.1128/AAC.47.1. 378-382.2003 (Pubitemid 36070390)
17. Soltero-Higgin M., Carlson E. E., Phillips J. H., Kiessling L. L., Identification of inhibitors for UDP-galactopyranose mutase. Journal of the American Chemical Society 2004 126 34 10532 10533 2-s2.0-4344593011 10.1021/ja048017v (Pubitemid 39129142)
18. Latge J. P., Galactofuranose containing molecules in Aspergillus fumigatus. Medical Mycology 2009 47 supplement 1 S104 S109 2-s2.0-67651094284 10.1080/13693780802258832
19. Barr K., Laine R. A., Lester R. L., Carbohydrate structures of three novel phosphoinositol-containing sphingolipids from the yeast Histoplasma capsulatum. Biochemistry 1984 23 23 5589 5596 2-s2.0-0021756491
20. Vaishnav V. V., Bacon B. E., O'Neill M., Cherniak R., Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67. Carbohydrate Research 1998 306 1-2 315 330 2-s2.0-0031745832 10.1016/S0008-6215(97)10058-1 (Pubitemid 28305000)
21. Latge J. P., Kobayashi H., Debeaupuis J. P., Diaquin M., Sarfati J., Wieruszeski J. M., Parra E., Bouchara J. P., Fournet B., Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infection and Immunity 1994 62 12 5424 5433 2-s2.0-0027945730 (Pubitemid 24364983)
22. Bernard M., Latgé J. P., Aspergillus fumigatus cell wall: composition and biosynthesis. Medical Mycology, Supplement 2001 39 supplement 1 9 17 2-s2.0-0035663318
23. Schmalhorst P. S., Krappmann S., Vervecken W., Rohde M., Müller M., Braus G. H., Contreras R., Braun A., Bakker H., Routier F. H., Contribution of galactofuranose to the virulence of the opportunistic pathogen Aspergillus fumigatus. Eukaryotic Cell 2008 7 8 1268 1277 2-s2.0-48949102782 10.1128/EC.00109-08
24. Engel J., Schmalhorst P. S., Dörk-Bousset T., Ferrières V., Routier F. H., A single UDP-galactofuranose transporter is required for galactofuranosylation in Aspergillus fumigatus. The Journal of Biological Chemistry 2009 284 49 33859 33868 2-s2.0-71749116070 10.1074/jbc.M109.070219
25. Kleczka B., Lamerz A. C., van Zandbergen G., Wenzel A., Gerardy-Schahn R., Wiese M., Routier F. H., Targeted gene deletion of Leishmania major UDP-galactopyranose mutase leads to attenuated virulence. The Journal of Biological Chemistry 2007 282 14 10498 10505 2-s2.0-34249852365 10.1074/jbc.M700023200 (Pubitemid 47093425)
26. de Lederkremer R. M., Colli W., Galactofuranose-containing glycoconjugates in trypanosomatids. Glycobiology 1995 5 6 547 552 2-s2.0-0028789599
27. de Lederkremer R. M., Agusti R., Chapter 7 Glycobiology of Trypanosoma cruzi. Advances in Carbohydrate Chemistry and Biochemistry 2009 62 311 366 2-s2.0-66249110345 10.1016/S0065-2318(09)00007-9
28. Coura J. R., Borges-Pereira J., Chagas disease: 100 years after its discovery. A systemic review. Acta Tropica 2010 115 1-2 5 13 2-s2.0-77953024222 10.1016/j.actatropica.2010.03.008
29. De Souza W., Basic cell biology of Trypanosoma cruzi. Current Pharmaceutical Design 2002 8 4 269 285 2-s2.0-0036242661 10.2174/ 1381612023396276 (Pubitemid 34449883)
30. Kato H., Gomez E. A., Cáceres A. G., Uezato H., Mimori T., Hashiguchi Y., Molecular epidemiology for vector research on leishmaniasis. International Journal of Environmental Research and Public Health 2010 7 3 814 826 2-s2.0-77950891280 10.3390/ijerph7030814
31. Urbina J. A., Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Tropica 2010 115 1-2 55 68 2-s2.0-77953082627 10.1016/j.actatropica.2009.10.023
32. Kedzierski L., Sakthianandeswaren A., Curtis J. M., Andrews P. C., Junk P. C., Kedzierska K., Leishmaniasis: current treatment and prospects for new drugs and vaccines. Current Medicinal Chemistry 2009 16 5 599 614 2-s2.0-63149112758 10.2174/092986709787458489
33. Richard J. V., Werbovetz K. A., New antileishmanial candidates and lead compounds. Current Opinion in Chemical Biology 2010 14 447 455 2-s2.0-77950831059 10.1016/j.cbpa.2010.03.023
34. Ferguson M. A. J., The surface glycoconjugates of trypanosomatid parasites. Philosophical Transactions of the Royal Society B: Biological Sciences 1997 352 1359 1295 1302 2-s2.0-0031590269 10.1098/rstb.1997.0113 (Pubitemid 27434093)
35. Turco S. J., Descoteaux A., The lipophosphoglycan of Leishmania parasites. Annual Review of Microbiology 1992 46 65 94 2-s2.0-0026746610
36. Golgher D. B., Colli W., Souto-Padron T., Zingales B., Galactofuranose-containing glycoconjugates of epimastigote and trypomastigote forms of Trypanosoma cruzi. Molecular and Biochemical Parasitology 1993 60 2 249 264 2-s2.0-0027216312 10.1016/0166-6851(93)90136-L
37. Frey P. A., The Leloir pathway: a mechanistic imperative for three enzymes to change the stereochemical configuration of a single carbon in galactose. The FASEB Journal 1996 10 4 461 470 2-s2.0-0029920614 (Pubitemid 26120321)
38. Holden H. M., Rayment I., Thoden J. B., Structure and function of enzymes of the leloir pathway for galactose metabolism. The Journal of Biological Chemistry 2003 278 45 43885 43888 2-s2.0-0242498430 10.1074/jbc.R300025200 (Pubitemid 37377125)
39. Isselbacher K. J., Evidence for an accessory pathway of galactose metabolism in mammalian liver. Science 1957 126 3275 652 654 2-s2.0-0041530874
40. Turco S. J., Wilkerson M. A., Clawson D. R., Expression of an unusual acidic glycoconjugate in Leishmania donovani. The Journal of Biological Chemistry 1984 259 6 3883 3889 2-s2.0-0021323610 (Pubitemid 14170104)
41. Damerow S., Lamerz A. C., Haselhorst T., Führing J., Zarnovican P., von Itsztein M., Routier F. H., Leishmania UDP-sugar pyrophosphorylase: the missing link in galactose salvage? The Journal of Biological Chemistry 2010 285 2 878 887 2-s2.0-74049128731 10.1074/jbc.M109.067223
42. Dickmanns A., Damerow S., Neumann P., Schulz E.-C., Lamerz A.-C., Routier F. H., Ficner R., rficner@gwdg.de Structural basis for the broad substrate range of the UDP-sugar pyrophosphorylase from leishmania major. Journal of Molecular Biology 2011 405 2 461 478 10.1016/j.jmb.2010.10.057
43. Lamerz A.-C., Damerow S., Kleczka B., Wiese M., Van Zandbergen G., Lamerz J., Wenzel A., Hsu F.-F., Turk J., Beverley S. M., Routier F. H., Routier.Francoise@mh-hannover.de Deletion of UDP-glucose pyrophosphorylase reveals a UDP-glucose independent UDP-galactose salvage pathway in Leishmania major. Glycobiology 2010 20 7 872 882 10.1093/glycob/cwq045
44. Eisenthal R., Game S., Holman G. D., Specificity and kinetics of hexose transport in Trypanosoma brucei. Biochimica et Biophysica Acta 1989 985 1 81 89 2-s2.0-0024959890
45. Roper J. R., Güther M. L. S., Milne K. G., Ferguson M. A. J., Galactose metabolism is essential for the african sleeping sickness parasite Trypanosoma brucei. Proceedings of the National Academy of Sciences of the United States of America 2002 99 9 5884 5889 2-s2.0-0037197847 10.1073/pnas.092669999 (Pubitemid 34493234)
46. Carver M. A., Turco S. J., Cell-free biosynthesis of lipophosphoglycan from Leishmania donovani: characterization of microsomal galactosyltransferase and mannosyltransferase activities. The Journal of Biological Chemistry 1991 266 17 10974 10981 2-s2.0-0025770425 (Pubitemid 21906899)
47. Späth G. F., Garraway L. A., Turco S. J., Beverley S. M., The role(s) of lipophosphoglycan (LPG) in the establishment of Leishmania major infections in mammalian hosts. Proceedings of the National Academy of Sciences of the United States of America 2003 100 16 9536 9541 2-s2.0-0043180475 10.1073/pnas.1530604100 (Pubitemid 37033963)
48. Turco S. J., Späth G. F., Beverley S. M., Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends in Parasitology 2001 17 5 223 226 2-s2.0-0035003815 10.1016/S1471-4922(01)01895-5 (Pubitemid 32422166)
49. Svárovská A., Ant T. H., Seblová V., Jecná L., Beverley S. M., Volf P., Leishmania major glycosylation mutants require phosphoglycans (pg2-) but not lipophosphoglycan (llpg1-) for survival in permissive sand fly vectors. PLoS Neglected Tropical Diseases 2010 4 1, article e580 2-s2.0-76249111171 10.1371/journal.pntd.0000580
50. Butcher B. A., Turco S. J., Hilty B. A., Pimentai P. F., Panunzio M., Sacks D. L., Deficiency in β 1,3-galactosyltransferase of a Leishmania major lipophosphoglycan mutant adversely influences the Leishmania-sand fly interaction. The Journal of Biological Chemistry 1996 271 34 20573 20579 2-s2.0-0029664952 10.1074/jbc.271.34.20573 (Pubitemid 26281834)
51. McConville M. J., Homans S. W., Thomas-Oates J. E., Dell A., Bacic A., Structures of the glycoinositolphospholipids from Leishmania major. A family of novel galactofuranose-containing glycolipids. The Journal of Biological Chemistry 1990 265 13 7385 7394 2-s2.0-0025305252
52. de Lederkremer R. M., Casal O. L., Alves M. J., Colli W., Evidence for the presence of D-galactofuranose in the lipopeptidophosphoglycan from Trypanosome cruzi. Modification and tritium labeling. The FEBS Letters 1980 116 1 25 29 2-s2.0-0019322314 10.1016/0014-5793(80)80521-7
53. Mendona-Previato L., Gorin P. A. J., Braga A. F., Scharfstein J., Previato J. O., Chemical structure and antigenic aspects of complexes obtained from epimastigotes of Trypanosome cruzi. Biochemistry 1983 22 21 4980 4987 2-s2.0-0021101206
54. de Lederkremer R. M., Lima C., Ramirez M. I., Ferguson M. A. J., Homans S. W., Thomas-Oates J., Complete structure of the glycan of lipopeptidophosphoglycan from Trypanosome cruzi epimastigotes. The Journal of Biological Chemistry 1991 266 35 23670 23675 2-s2.0-0026334201
55. Nogueira N. F. S., Gonzalez M. S., Gomes J. E., de Souza W., Garcia E. S., Azambuja P., Nohara L. L., Almeida I. C., Zingales B., Colli W., Trypanosome cruzi: involvement of glycoinositolphospholipids in the attachment to the luminal midgut surface of Rhodnius prolixus. Experimental Parasitology 2007 116 2 120 128 2-s2.0-34247143774 10.1016/j.exppara.2006.12.014 (Pubitemid 46602253)
56. Ferguson M. A. J., The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of Trypanosome research. Journal of Cell Science 1999 112 17 2799 2809 2-s2.0-0032820595 (Pubitemid 29430025)
57. Suzuki E., Tanaka A. K., Toledo M. S., Levery S. B., Straus A. H., Takahashi H. K., Trypanosomatid and fungal glycolipids and sphingolipids as infectivity factors and potential targets for development of new therapeutic strategies. Biochimica et Biophysica Acta 2008 1780 3 362 369 2-s2.0-40849083930 10.1016/j.bbagen.2007.09.009 (Pubitemid 351391899)
58. Carreira J. C., Jones C., Wait R., Previato J. O., Mendona-Previato L., Structural variation in the glycoinositolphospholipids of different strains of Trypanosome cruzi. Glycoconjugate Journal 1996 13 6 955 966 2-s2.0-0029730662 (Pubitemid 26421840)
59. McConville M. J., Ferguson M. A. J., The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochemical Journal 1993 294 2 305 324 2-s2.0-0027257177 (Pubitemid 23268825)
60. Suzuki E., Tanaka A. K., Toledo M. S., Takahashi H. K., Straus A. H., Role of β -D-galactofuranose in Leishmania major macrophage invasion. Infection and Immunity 2002 70 12 6592 6596 2-s2.0-0036892846 10.1128/IAI.70.12.6592-6596.2002 (Pubitemid 35387886)
61. de Lederkremer R. M., Lima C. E., Ramirez M. I., Goncalvez M. F., Colli W., Hexadecylpalmitoylglycerol or ceramide is linked to similar glycophosphoinositol anchor-like structures in Trypanosome cruzi. European Journal of Biochemistry 1993 218 3 929 936 2-s2.0-0027146046 10.1111/j.1432-1033.1993.tb18449.x (Pubitemid 24010059)
62. de Lederkremer R. M., Free and protein-linked glycoinositolphospholipids in Trypanosome cruzi. Brazilian Journal of Medical and Biological Research 1994 27 2 239 242 2-s2.0-0028373563
63. Previato J. O., Wait R., Jones C., DosReis G. A., Todeschini A. R., Heise N., Mendona Previato L., Glycoinositolphospholipid from Trypanosome cruzi: structure, biosynthesis and immunobiology. Advances in Parasitology 2003 56 1 41 2-s2.0-0348014425 10.1016/S0065-308X(03)56001-8 (Pubitemid 37532270)
64. MacRae J. I., Acosta-Serrano A., Morrice N. A., Mehlert A., Ferguson M. A. J., Structural characterization of NETNES, a novel glycoconjugate in Trypanosome cruzi epimastigotes. The Journal of Biological Chemistry 2005 280 13 12201 12211 2-s2.0-16844382485 10.1074/jbc.M412939200
65. Pereira-Chioccola V. L., Acosta-Serrano A., de Almeida I. C., Ferguson M. A. J., Souto-Padron T., Rodrigues M. M., Travassos L. R., Schenkman S., Mucin-like molecules form a negatively charged coat that protects Trypanosome cruzi trypomastigotes from killing by human anti- α -galactosyl antibodies. Journal of Cell Science 2000 113 7 1299 1307 2-s2.0-0034012169 (Pubitemid 30229546)
66. Suzuki E., Mortara R. A., Takahashi H. K., Straus A. H., Reactivity of MEST-1 (Antigalactofuranose) with Trypanosome cruzi glycosylinositol phosphorylceramides (GIPCs): immunolocalization of gipcs in acidic vesicles of epimastigotes. Clinical and Diagnostic Laboratory Immunology 2001 8 5 1031 1035 10.1128/CDLI.8.5.1031-1035.2001 (Pubitemid 32868329)
67. Moraes C. T., Bosch M., Parodi A. J., Structural characterization of several galactofuranose-containing, high-mannose-type oligosaccharides present in glycoproteins of the trypanosomatid leptomonas samueli. Biochemistry 1988 27 5 1543 1549 2-s2.0-0024281293
68. Mendelzon D. H., Previato J. O., Parodi A. J., Characterization of protein-linked oligosaccharides in trypanosomatid flagellates. Molecular and Biochemical Parasitology 1986 18 3 355 367 2-s2.0-0022625478 (Pubitemid 16125643)
69. Mendelzon D. H., Parodi A. J., N-linked high mannose-type oligosaccharides in the protozoa Crithidia fasciculata and Crithidia harmosa contain galactofuranose residues. The Journal of Biological Chemistry 1986 261 5 2129 2133 2-s2.0-0022970907 (Pubitemid 17205138)
70. Turnock D. C., Ferguson M. A. J., Sugar nucleotide pools of Trypanosome brucei, Trypanosome cruzi, and Leishmania major. Eukaryotic Cell 2007 6 8 1450 1463 2-s2.0-34547911022 10.1128/EC.00175-07 (Pubitemid 47257714)
71. Buscaglia C. A., Campo V. A., Frasch A. C., Di Noia J. M., Trypanosome cruzi surface mucins: host-dependent coat diversity. Nature Reviews. Microbiology 2006 4 3 229 236 2-s2.0-33645966218 10.1038/nrmicro1351
72. Jones C., Todeschini A. R., Agrellos O. A., Previato J. O., Mendona-Previato L., Heterogeneity in the biosynthesis of mucin O-glycans from Trypanosome cruzi Tulahuen strain with the expression of novel galactofuranosyl-containing oligosaccharides. Biochemistry 2004 43 37 11889 11897 2-s2.0-4644345296 10.1021/bi048942u (Pubitemid 39277636)
73. Agrellos O. A., Jones C., Todeschini A. R., Previato J. O., Mendona-Previato L., A novel sialylated and galactofuranose-containing O-linked glycan, Neu5Ac α 2→3Galp β 1→6(Galf β 1→4)GlcNAc, is expressed on the sialoglycoprotein of Trypanosome cruzi Dm28c. Molecular and Biochemical Parasitology 2003 126 1 93 96 2-s2.0-12244302880 10.1016/S0166-6851(02)00245-1 (Pubitemid 36120608)
74. Previato J. O., Jones C., Goncalves L. P. B., Wait R., Travassos L. R., Mendonca-Previato L., O-Glycosidically linked N-acetylglucosamine-bound oligosaccharides from glycoproteins of Trypanosome cruzi. Biochemical Journal 1994 301 1 151 159 2-s2.0-0028180378
75. Serrano A. A., Schenkman S., Yoshida N., Mehlert A., Richardson J. M., Ferguson M. A. J., The lipid structure of the glycosylphosphatidylinositol- anchored mucin- like sialic acid acceptors of Trypanosome cruzi changes during parasite differentiation from epimastigotes to infective metacyclic trypomastigote forms. The Journal of Biological Chemistry 1995 270 45 27244 27253 2-s2.0-0028818843 10.1074/jbc.270.45.27244
76. Almeida I. C., Ferguson M. A. J., Schenkman S., Travassos L. R., Lytic anti- α -galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl- phosphatidylinositol-anchored glycoproteins of Trypanosome cruzi. Biochemical Journal 1994 304 3 793 802
77. Acosta-Serrano A., Almeida I. C., Freitas-Junior L. H., Yoshida N., Schenkman S., The mucin-like glycoprotein super-family of Trypanosome cruzi: structure and biological roles. Molecular and Biochemical Parasitology 2001 114 2 143 150 2-s2.0-0034986265 10.1016/S0166-6851(01)00245-6 (Pubitemid 32510751)
78. Todeschini A. R., da Silveira E. X., Jones C., Wait R., Previato J. O., Mendona-Previato L., Structure of O-glycosidically linked oligosaccharides from glycoproteins of Trypanosome cruzi CL-Brener strain: evidence for the presence of o-linked sialyl-oligosaccharides. Glycobiology 2001 11 1 47 55 2-s2.0-0035097718 (Pubitemid 32201336)
79. Previato J. O., Jones C., Xavier M. T., Wait R., Travassos L. R., Parodi A. J., Mendonca-Previato L., Structural characterization of the major glycosylphosphatidylinositol membrane-anchored glycoprotein from epimastigote forms of Trypanosome cruzi Y-strain. The Journal of Biological Chemistry 1995 270 13 7241 7250 2-s2.0-0028958148 10.1074/jbc.270.13.7241
80. Suzuki E., Toledo M. S., Takahashi H. K., Straus A. H., A monodonal antibody directed to terminal residue of β -galactofuranose of a glycolipid antigen isolated from Paracoccidioides brasiliensis: cross-reactivity with Leishmania major and Trypanosome cruzi. Glycobiology 1997 7 4 463 468 10.1093/glycob/7.4.463 (Pubitemid 27246719)
81. De Arruda M. V., Colli W., Zingales B., Terminal β -D-galactofuranosyl epitopes recognized by antibodies that inhibit Trypanosome cruzi internalization into mammalian cells. European Journal of Biochemistry 1989 182 2 413 421 2-s2.0-0024320726 (Pubitemid 19165427)
82. MacRae J. I., Obado S. O., Turnock D. C., Roper J. R., Kierans M., Kelly J. M., Ferguson M. A. J., The suppression of galactose metabolism in Trypanosome cruzi epimastigotes causes changes in cell surface molecular architecture and cell morphology. Molecular and Biochemical Parasitology 2006 147 1 126 136 2-s2.0-33645902165 10.1016/j.molbiopara.2006.02.011
83. Oppermann U., Filling C., Hult M., Shafqat N., Wu X., Lindh M., Shafqat J., Nordling E., Kallberg Y., Persson B., Jörnvall H., Short-chain dehydrogenases/reductases (SDR): the 2002 update. Chemico-Biological Interactions 2003 143-144 247 253 2-s2.0-12744267344 10.1016/S0009-2797(02) 00164-3 (Pubitemid 36253589)
84. Shaw M. P., Bond C. S., Roper J. R., Gourley D. G., Ferguson M. A. J., Hunter W. N., High-resolution crystal structure of Trypanosome brucei UDP-galactose 4′-epimerase: a potential target for structure-based development of novel trypanocides. Molecular and Biochemical Parasitology 2003 126 2 173 180 2-s2.0-0037327814 10.1016/S0166-6851(02)00243-8 (Pubitemid 36255616)
85. Alphey M. S., Burton A., Urbaniak M. D., Boons G. J., Ferguson M. A. J., Hunter W. N., Trypanosome brucei UDP-galactose-4′-epimerase in ternary complex with NAD and the substrate analogue UDP-4-deoxy-4-fluoro- α -D- galactose. Acta Crystallographica Section F: Structural Biology and Crystallization Communications 2006 62 9 829 834 2-s2.0-33748502768 10.1107/S1744309106028740 (Pubitemid 44357711)
86. Roper J. R., Güther M. L. S., MacRae J. I., Prescott A. R., Hallyburton I., Acosta-Serrano A., Ferguson M. A. J., The suppression of galactose metabolism in procylic form Trypanosome brucei causes cessation of cell growth and alters procyclin glycoprotein structure and copy number. The Journal of Biological Chemistry 2005 280 20 19728 19736 2-s2.0-21244496004 10.1074/jbc.M502370200 (Pubitemid 41379498)
87. Urbaniak M. D., Turnock D. C., Ferguson M. A. J., Galactose starvation in a bloodstream form Trypanosome brucei UDP-glucose 4′-epimerase conditional null mutant. Eukaryotic Cell 2006 5 11 1906 1913 2-s2.0-33751186348 10.1128/EC.00156-06
88. Burchmore R. J. S., Rodriguez-Contrerast D., McBride K., Barrett M. P., Modi G., Sacks D., Landfeart S. M., Genetic characterization of glucose transporter function in Leishmania mexicana. Proceedings of the National Academy of Sciences of the United States of America 2003 100 7 3901 3906 2-s2.0-0037388072 10.1073/pnas.0630165100 (Pubitemid 36418129)
89. Urbaniak M. D., Tabudravu J. N., Msaki A., Matera K. M., Brenk R., Jaspars M., Ferguson M. A. J., Identification of novel inhibitors of UDP-Glc 4′-epimerase, a validated drug target for african sleeping sickness. Bioorganic and Medicinal Chemistry Letters 2006 16 22 5744 5747 2-s2.0-33749258363 10.1016/j.bmcl.2006.08.091 (Pubitemid 44486749)
90. Durrant J. D., Urbaniak M. D., Ferguson M. A. J., McCammon J. A., Computer-aided identification of Trypanosome brucei uridine diphosphate galactose 4′ -epimerase inhibitors: toward the development of novel therapies for African sleeping sickness. Journal of Medicinal Chemistry 2010 53 13 5025 5032 2-s2.0-77954343124 10.1021/jm100456a
91. Sanders D. A. R., McMahon S. A., Leonard G. L., Naismith J. H., Molecular placement of experimental electron density: a case study on UDP-galactopyranose mutase. Acta Crystallographica-Section D Biological Crystallography 2001 57 10 1415 1420 2-s2.0-0035788098 10.1107/S0907444901009829 (Pubitemid 36117191)
92. Beis K., Srikannathasan V., Liu H., Fullerton S. W. B., Bamford V. A., Sanders D. A. R., Whitfield C., McNeil M. R., Naismith J. H., Crystal structures of Mycobacteria tuberculosis and Klebsiella pneumoniae UDP-galactopyranose Mutase in the oxidised state and Klebsiella pneumoniae UDP-galactopyranose mutase in the (active) reduced state. Journal of Molecular Biology 2005 348 4 971 982 2-s2.0-17444429638 10.1016/j.jmb.2005.02.057 (Pubitemid 40544395)
93. Oppenheimer M., Poulin M. B., Lowary T. L., Helm R. F., Sobrado P., psobrado@vt.edu Characterization of recombinant UDP-galactopyranose mutase from Aspergillus fumigatus. Archives of Biochemistry and Biophysics 2010 502 1 31 38 10.1016/j.abb.2010.06.035
94. Gouet P., Courcelle E., Stuart D. I., Métoz F., ESPript: analysis of multiple sequence alignments in PostScript. Bioinformatics 1999 15 4 305 308 2-s2.0-0032961270 10.1093/bioinformatics/15.4.305 (Pubitemid 29213756)
95. El-Ganiny A. M., Sanders D. A. R., Kaminskyj S. G. W., Aspergillus nidulans UDP-galactopyranose mutase, encoded by ugmA plays key roles in colony growth, hyphal morphogensis, and conidiation. Fungal Genetics and Biology 2008 45 12 1533 1542 2-s2.0-56049113754 10.1016/j.fgb.2008.09.008
96. Zhang Q., Liu H. W., Studies of UDP-galactopyranose mutase from Escherichia coli: an unusual role of reduced FAD in its catalysis. Journal of the American Chemical Society 2000 122 38 9065 9070 2-s2.0-0034721448 10.1021/ja001333z
97. Sanders D. A. R., Staines A. G., McMahon S. A., McNeil M. R., Whitfield C., Naismith J. H., UDP-galactopyranose mutase has a novel structure and mechanism. Nature Structural Biology 2001 8 10 858 863 2-s2.0-0034815662 10.1038/nsb1001-858 (Pubitemid 32923604)
98. Soltero-Higgin M., Carlson E. E., Gruber T. D., Kiessling L. L., A unique catalytic mechanism for UDP-galactopyranose mutase. Nature Structural and Molecular Biology 2004 11 6 539 543 2-s2.0-2542428317 10.1038/nsmb772 (Pubitemid 38691921)
99. Gruber T. D., Westler W. M., Kiessling L. L., Forest K. T., X-Ray crystallography reveals a reduced substrate complex of UDP-galactopyranose mutase poised for covalent catalysis by flavin. Biochemistry 2009 48 39 9171 9173 2-s2.0-70349620864 10.1021/bi901437v
100. Huang Z., Zhang Q., Liu H. W., Reconstitution of UDP-galactopyranose mutase with 1-deaza-FAD and 5-deaza-FAD: analysis and mechanistic implications. Bioorganic Chemistry 2003 31 6 494 502 2-s2.0-0242468752 10.1016/j.bioorg.2003. 08.002 (Pubitemid 37378223)
101. Karunan Partha S., van Straaten K. E., Sanders D. A. R., Structural basis of substrate binding to UDP-galactopyranose mutase: crystal structures in the reduced and oxidized state complexed with UDP-galactopyranose and UDP. Journal of Molecular Biology 2009 394 5 864 877 2-s2.0-70449674082 10.1016/j.jmb.2009. 10.013
102. Ha D. S., Schwarz J. K., Turco S. J., Beverley S. M., Use of the green fluorescent protein as a marker in transfected Leishmania. Molecular and Biochemical Parasitology 1996 77 1 57 64 2-s2.0-0343267840 10.1016/0166-6851(96) 02580-7 (Pubitemid 26186162)
103. Späth G. F., Epstein L., Leader B., Singer S. M., Avila H. A., Turco S. J., Beverley S. M., Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proceedings of the National Academy of Sciences of the United States of America 2000 97 16 9258 9263 2-s2.0-0034255342 10.1073/pnas.160257897 (Pubitemid 30626706)
104. Zhang K., Barron T., Turco S. J., Beverley S. M., The LPG1 gene family of Leishmania major. Molecular and Biochemical Parasitology 2004 136 1 11 23 2-s2.0-2342568876 10.1016/j.molbiopara.2004.02.012 (Pubitemid 38597116)
105. Ryan K. A., Garraway L. A., Descoteaux A., Turco S. J., Beverley S. M., Isolation of virulence genes directing surface glycosyl- phosphatidylinositol synthesis by functional complementation of Leishmania. Proceedings of the National Academy of Sciences of the United States of America 1993 90 18 8609 8613 2-s2.0-0027227645 (Pubitemid 23277719)
106. El-Sayed N. M., nelsayed@tigr.org Myler P. J., peter.myler@sbri.org Bartholomeu D. C., Nilsson D., Aggarwal G., Tran A.-N., Ghedin E., Worthey E. A., Delcher A. L., Blandin G., Westenberger S. J., Caler E., Cerqueira G. C., Branche C., Haas B., Anupama A., Arner E., Åslund L., Attipoe P., Bontempi E., Bringaud F., Burton P., Cadag E., Campbell D. A., Carrington M., Crabtree J., Darban H., Da Silveira J. F., De Jong P., Edwards K., Englund P. T., Fazelina G., Feldblyum T., Ferella M., Frasch A. C., Gull K., Horn D., Hou L., Huang Y., Kindlund E., Klingbeil M., Kluge S., Koo H., Lacerda D., Levin M. J., Lorenzi H., Louie T., Machado C. R., McCulloch R., McKenna A., Mizuno Y., Mottram J. C., Nelson S., Ochaya S., Osoegawa K., Pai G., Parsons M., Pentony M., Pettersson U., Pop M., Ramirez J. L., Rinta J., Robertson L., Salzberg S. L., Sanchez D. O., Seyler A., Sharma R., Shetty J., Simpson A. J., Sisk E., Tammi M. T., Tarleton R., Teixeira S., Van Aken S., Vogt C., Ward P. N., Wickstead B., Wortman J., White O., Fraser C. M., Stuart K. D., Andersson B., bjorn.andersson@cgb.ki.se The genome sequence of Trypanosoma cruzi, etiologic agent of chagas disease. Science 2005 309 5733 409 415+435 10.1126/science. 1112631 (Pubitemid 40994675)
107. El-Sayed N. M., nelsayed@tigr.org Myler P. J., peter.myler@sbri.org Blandin G., Berriman M., Crabtree J., Aggarwal G., Caler E., Renauld H., Worthey E. A., Hertz-Fowler C., Ghedin E., Peacock C., Bartholomeu D. C., Haas B. J., Tran A.-N., Wortman J. R., Alsmark U. C.M., Angiuoli S., Anupama A., Badger J., Bringaud F., Cadag E., Carlton J. M., Cerqueira G. C., Creasy T., Delcher A. L., Djikeng A., Embley T. M., Hauser C., Ivens A. C., Kummerfeld S. K., Pereira-Leal J. B., Nilsson D., Peterson J., Salzberg S. L., Shallom J., Silva J. C., Sundaram J., Westenberger S., White O., Melville S. E., Donelson J. E., Andersson B., Stuart K. D., Hall N., nhall@tigr.org Comparative genomics of trypanosomatid parasitic protozoa. Science 2005 309 5733 404 409+435 10.1126/science.1112181 (Pubitemid 40994674)
108. Kapitonov D., Yu R. K., Conserved domains of glycosyltransferases. Glycobiology 1999 9 10 961 978 2-s2.0-0032844594 10.1093/glycob/9.10.961 (Pubitemid 29473953)
109. Pedersen L. L., Turco S. J., Galactofuranose metabolism: a potential target for antimicrobial chemotherapy. Cellular and Molecular Life Sciences 2003 60 2 259 266 2-s2.0-0037301077 10.1007/s000180300021 (Pubitemid 36343906)